好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Smaller baseline brain volume and higher atrophy rate over two years is associated with poorer clinical outcomes: post hoc analysis of the MS-STAT trial in Secondary Progressive MS
Multiple Sclerosis
(-)
259
Authors/Disclosures
Jeremy S. Chataway, MD
PRESENTER 		Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
No disclosure on file
No disclosure on file
No disclosure on file
Ali Alsanousi, MD, MBBS, PhD, Msc I (Al Neelain Univversity, Faculty of Medicine and Health Science) No disclosure on file
Dennis Chan, MD, PhD, FRCP (Clinical Imaging Sciences Centre) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Richard S. Nicholas, FRCP (Imperial College Healthcare Trust) Dr. Nicholas has nothing to disclose.